Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-03-05 02:29 | 2019-03-01 | PTGX | Protagonist Therapeutics, Inc | Shames Richard S. | Officer; Chief Medical Officer | Pharmaceutical Preparations | SALE | $8.03 | 657 | $5,276 | 32,021 | -2.0% |
| 2019-02-09 01:27 | 2019-02-06 | PTGX | Protagonist Therapeutics, Inc | Shames Richard S. | Officer; Chief Medical Officer | Pharmaceutical Preparations | SALE | $7.74 | 2,778 | $21,506 | 24,178 | -10.3% |
| 2017-12-27 22:07 | 2017-12-22 | PTGX | Protagonist Therapeutics, Inc | Shames Richard S. | Officer; Chief Medical Officer | Pharmaceutical Preparations | OPT+S | $20.50 | 3,529 | $72,345 | 0 | -100.0% |
| 2017-10-11 02:04 | 2017-10-05 | PTGX | Protagonist Therapeutics, Inc | Shames Richard S. | Officer; Chief Medical Officer | Pharmaceutical Preparations | OPT+S | $19.00 | 2,017 | $38,323 | 0 | -100.0% |
| 2017-09-13 02:50 | 2017-09-12 | PTGX | Protagonist Therapeutics, Inc | Shames Richard S. | Officer; Chief Medical Officer | Pharmaceutical Preparations | SALE | $14.31 | 3,687 | $52,753 | 0 | -100.0% |
| 2017-08-31 02:08 | 2017-08-29 | PTGX | Protagonist Therapeutics, Inc | Shames Richard S. | Officer; Chief Medical Officer | Pharmaceutical Preparations | OPT+S | $17.00 | 1,512 | $25,704 | 1,865 | -44.8% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.